SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-108802
Filing Date
2024-04-24
Accepted
2024-04-24 09:57:04
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d714101d10ka.htm   iXBRL 10-K/A 291767
2 EX-31.1 d714101dex311.htm EX-31.1 2402
3 EX-31.2 d714101dex312.htm EX-31.2 2378
  Complete submission text file 0001193125-24-108802.txt   551052

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xbit-20231231.xsd EX-101.SCH 4575
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20231231_cal.xml EX-101.CAL 657
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20231231_def.xml EX-101.DEF 16272
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20231231_lab.xml EX-101.LAB 22008
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20231231_pre.xml EX-101.PRE 17719
22 EXTRACTED XBRL INSTANCE DOCUMENT d714101d10ka_htm.xml XML 7831
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37347 | Film No.: 24867275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)